REST and neural gene network dysregulation in iPSC models of Alzheimer’s disease

Meyer, Katharina, Feldman, Heather M., Lu, Tao, Drake, Derek, Lim, Elaine T., Ling, King-Hwa, Bishop, Nicholas A., Pan, Ying +6 more·2019·Cell Reports
DOI 10.1016/j.celrep.2019.01.023

Cited by (218)

Items 101–200 of 218

  1. Sex-specific associations of gene expression with Alzheimer’s disease neuropathology and ante-mortem cognitive performance
    Mabel Seto, Michelle J. Clifton, Melisa Lara Gomez, Gillian Coughlan, Katherine A. Gifford, Angela Lee Jefferson, Philip L. De Jager, David A. Bennett, Yanling Wang, Lisa Laverne Barnes et al. · 2025 · Nature Communications
  2. Modeling neurodegenerative diseases with brain organoids: from development to disease applications
    Teresa Larriba-González, Marina García-Martín, Doddy Denise Ojeda-Hernández, Paula Rincón-Cerrada, Lucía Martín-Blanco, María Soledad Benito‐Martín, Belén Selma-Calvo, Sarah de la Fuente-Martín, Jordi A. Matías‐Guiu, Jorge Matías‐Guiu et al. · 2025 · Frontiers in Cell and Developmental Biology
  3. Identifying the earliest-occurring clinically targetable precursors of late-onset Alzheimer's disease
    Bruce M. Cohen, Kai‐Christian Sonntag · 2024 · EBioMedicine
  4. Establishment of Human-Induced Pluripotent Stem Cell-Derived Neurons—A Promising In Vitro Model for a Molecular Study of Rabies Virus and Host Interaction
    Thanathom Chailangkarn, Nathiphat Tanwattana, Thanakorn Jaemthaworn, Sira Sriswasdi, Nanchaya Wanasen, Sithichoke Tangphatsornruang, Kantinan Leetanasaksakul, Yuparat Jantraphakorn, Wanapinun Nawae, Penpicha Chankeeree et al. · 2021 · International Journal of Molecular Sciences
  5. Current Development of iPSC-Based Modeling in Neurodegenerative Diseases
    Xiangge Guo, Xumeng Wang, Jiaxuan Wang, Min Ma, Qian Ren · 2025 · International Journal of Molecular Sciences
  6. Systems biology of Alzheimer’s Disease: a scoping review of key pathways and mechanisms
    Paula J. Bice, Kwangsik T. Nho, Nilüfer Ertekin‐Taner, Andrew J. Saykin · 2026 · Molecular Neurodegeneration
  7. Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia
    Julie J. McInvale, Peter Canoll, Gunnar Hargus · 2024 · Brain Pathology
  8. Bottom-up Biomaterial strategies for creating tailored stem cells in regenerative medicine
    Brenda Cruz-Gonzalez, Ellie Johandes, Dominique Gramm, Donny Hanjaya‐Putra · 2025 · Frontiers in Bioengineering and Biotechnology
  9. REMOVED: Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide
    Hari Shanker Sharma, Dafin Fior Muresanu, Ala Nozari, José Vicente Lafuente, Anca Dana Buzoianu, Seaab Sahib, Z. Ryan Tian, Igor Bryukhovetskiy, Igor Manzhulo, Preeti Kumaran Menon et al. · 2021 · Progress in brain research
  10. Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models
    Md Fayad Hasan, Eugenia V. Trushina · 2022 · Brain Sciences
  11. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer’s Disease
    Jessica E. Young, Lawrence S.B. Goldstein · 2022 · Methods in molecular biology
  12. Single-nucleus RNA velocity reveals critical synaptic and cell-cycle dysregulations in neuropathologically confirmed Alzheimer’s disease
    Quadri Adewale, Ahmed Faraz Khan, David Alan Bennett, Yasser Iturria‐Medina · 2024 · Scientific Reports
  13. Alzheimer’s disease induced neurons bearing PSEN1 mutations exhibit reduced excitability
    Simon Maksour, Rocio K. Finol‐Urdaneta, Amy E. Hulme, Mauricio Castro Cabral-da-Silva, Helena Targa Dias Anastacio, Rachelle Balez, Tracey Berg, Calista Turner, Sonia Sanz Muñoz, Martin Engel et al. · 2024 · Frontiers in Cellular Neuroscience
  14. Brain Transcriptome Analysis Links Deficiencies of Stress-Responsive Proteins to the Pathomechanism of Kii ALS/PDC
    Satoru Morimoto, Mitsuru Ishikawa, Hirotaka Watanabe, Miho Isoda, Masaki Takao, Shiho Nakamura, Fumiko Ozawa, YOSHIFUMI S. HIROKAWA, Shigeki Kuzuhara, Hideyuki Okano et al. · 2020 · Antioxidants
  15. REST and Stress Resistance in the Aging Kidney
    Sato Magassa, Liviu Aron, Clément Hoguin, Pierre Isnard, Fabiola Terzi, Christophe M. Legendre, Bruce A. Yankner, Guillaume Canaud · 2021 · Journal of the American Society of Nephrology
  16. Generation and validation of APOE knockout human iPSC-derived cerebral organoids
    Yuka A. Martens, Siming Xu, Richard Tait, Gang Li, Xinping C. Zhao, Wenyan Lü, Chia‐Chen Liu, Takahisa Kanekiyo, Guojun Bu, Jing Zhao · 2021 · STAR Protocols
  17. Genotype by environment interactions for chronic wasting disease in farmed US white-tailed deer
    Christopher M. Seabury, Mitchell A. Lockwood, Tracy A. Nichols · 2022 · G3 Genes Genomes Genetics
  18. Large-scale cerebrospinal fluid proteomic analysis in Alzheimer’s disease patients reveals five molecular subtypes with distinct genetic risk profiles
    Tijms, Betty M, Vromen, Ellen M, Mjaavatten, Olav, Holstege, Henne, Reus, Lianne M, van der Lee, Sven, Wesenhagen, Kirsten EJ, Lorenzini, Luigi, Vermunt, Lisa, Venkatraghavan, Vikram et al. · 2023
  19. Spatiotemporal immunolocalisation of REST in the brain of healthy ageing and Alzheimer’s disease rats
    Myrthe Mampay, María Velasco‐Estevez, Sara O. Rolle, Aisling M. Chaney, Hervé Boutin, Kumlesh Kumar Dev, Emad Moeendarbary, Graham K. Sheridan · 2020 · FEBS Open Bio
  20. Neuromyelitis optica (NMO)‐IgG‐driven organelle reorganization in human iPSC‐derived astrocytes
    Sukhee Cho, Hyein G. Lee, Minkyo Jung, Kirim Hong, Seung‐Hwa Woo, Young‐Sam Lee, Byoung Joon Kim, Mi Young Jeon, Jinsoo Seo, Ji Young Mun · 2021 · The FASEB Journal
  21. Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
    Rebecca L. Pinals, Li‐Huei Tsai · 2022 · Life Science Alliance
  22. Patient-derived iPSCs, a reliable in vitro model for the investigation of Alzheimer’s disease
    Ernest Amponsah Asiamah, Ruiyun Guo, Desheng Kong, Baofeng Feng, Jingjing He, Wei Zhang, Xin Liu, Xiaofeng Du, Zhenhuan Ma, Boxin Liu et al. · 2021 · Reviews in the Neurosciences
  23. Increased GABAergic development in iPSC-derived neurons from patients with sporadic Alzheimer’s disease
    Yueyu Tang, Yingying Han, Hongxiang Yu, Bei Zhang, Gang Li · 2020 · Neuroscience Letters
  24. The Role of BMI1 in Late-Onset Sporadic Alzheimer’s Disease
    Ryan Hogan, Anthony Flamier, Eleonora Nardini, Gilbert Bernier · 2020 · Genes
  25. Neuronal Stem Cells from Late-Onset Alzheimer Patients Show Altered Regulation of Sirtuin 1 Depending on Apolipoprotein E Indicating Disturbed Stem Cell Plasticity
    Matthias Jung, Juliane‐Susanne Jung, Jenny Pfeifer, Carla Hartmann, Toni Ehrhardt, Chaudhry Luqman Abid, Jenny Kintzel, Anne Puls, Anne Navarrete Santos, Thomas Hollemann et al. · 2023 · Molecular Neurobiology
  26. Impaired neural stress resistance and loss of REST in bipolar disorder
    Katharina Meyer, King‐Hwa Ling, Pei Ling Yeo, Angeliki Spathopoulou, Derek Drake, Jaejoon Choi, Liviu Aron, Mariana García-Corral, Tak Ko, Eunjung Alice Lee et al. · 2023 · Molecular Psychiatry
  27. Apolipoprotein E expression pattern in human induced pluripotent stem cells during in vitro neural induction
    Hyun Ah Lee, Graham D. Cocks, Paulina Nowosiad, Lucia Dutan Polit, Jack Price, Deepak P. Srivas, Sandrine Thuret · 2020 · F1000Research
  28. Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
    B. Calvo, Pierre Schembri-Wismayer, M. B. Durán-Alonso · 2025 · Cells
  29. Modeling SARS-CoV-2 infection in individuals with opioid use disorder with brain organoids
    Moshe J. Willner, Yang Xiao, Hye Sung Kim, Xuejing Chen, Bin Xu, Kam W. Leong · 2021 · Journal of Tissue Engineering
  30. Regulation of mRNA translation in stem cells; links to brain disorders.
    Elpida Statoulla, K. Chalkiadaki, Dimitris Karozis, C. Gkogkas · 2021 · Cellular Signalling
  31. Cerebral organoids for modeling of HSV-1-induced-multiscale neuropathology associated with Alzheimer’s disease and phenotypic rescue
    Haowen Qiao, Wen Zhao, Moujian Guo, Lili Zhu, Tao Chen, Jibo Wang, Zhentao Zhang, Ying Wu, Pu Chen · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  32. Advancements in the in vitro culture of human pluripotent stem cells: progress, challenges, and future directions: comprehensive review
    Niraj Chaudhary, Luis Gerardo Villa-Diaz · 2025 · Frontiers in Toxicology
  33. Synaptic adhesion molecule protocadherin‐γC5 mediates β‐amyloid‐induced neuronal hyperactivity and cognitive deficits in Alzheimer's disease
    Min Su, Erying Xuan, Xiangyi Sun, Gaojie Pan, Dandan Li, Honghua Zheng, Yun‐wu Zhang, Yanfang Li · 2024 · Journal of Neurochemistry
  34. Detection of REST expression in the testis using epitope‐tag knock‐in mice generated by genome editing
    Ryuichi Kimura, Yukiko Inoue, Takako Kikkawa, Misako Tatehana, Yuki Morimoto, Hitoshi Inada, Shinya Oki, Takayoshi Inoue, Noriko Osumi · 2021 · Developmental Dynamics
  35. Directed Differentiation of Neurons from Human iPSCs for Modeling Neurological Disorders
    Cheng Wang, Jonas Cerneckis, Yanhong Shi · 2024 · Methods in molecular biology
  36. A Nuclear Belt Fastens on Neural Cell Fate
    Iván Mestres, Judith Houtman, Federico Calegari, Tomohisa Toda · 2022 · Cells
  37. microRNA-132 attenuates inflammation in induced pluripotent stem cell-derived microglia from Alzheimer’s disease patients
    Penning, Amber, Snoeck, Sarah, Ormaechea, Olmo Ruiz, Ayyildiz, Dilara, Polzer, Oliver, Buitrago-Arango, Martin, Capobianco, Raffaella, de Winter, Fred, Balusu, Sriram, Verhaagen, Joost et al. · 2026 · Acta Neuropathologica Communications
  38. Identification of SLC7A1 as a potential therapeutic target for high-grade meningioma
    Lairong Song, Xiaojie Li, Da Li, Kaibing Tian, Ke Wang, Junting Zhang, Liang Wang, Zhen Wu · 2025 · Cell Death Discovery
  39. The Regulatory Roles of REST in the Synaptic Development, Function and Related Neurological Disorders
    Chong Teik Lim, Cheng Wei Lim, Tan Huang, Elysha Nur Ismail, Parham Reisi, Pike-See Cheah, King‐Hwa Ling · 2025 · Journal of Neurochemistry
  40. Untangling the complex mechanisms associated with Alzheimer's disease in elderly patients using high-throughput RNA sequencing data and next-generation knowledge discovery methods: Focus on potential gene signatures and drugs for dementia
    Hind Ali Alkhatabi, Peter Natesan Pushparaj · 2024 · Heliyon
  41. Human cerebral organoids: Complex, versatile, and human-relevant models of neural development and brain diseases
    Raquel Coronel, Rosa González-Sastre, Patricia Mateos-Martínez, Laura Maeso, Elena Llorente-Beneyto, Sabela Martín-Benito, Viviana Stephanie Costa Gagosian, Leonardo Foti, María del Carmén González, Victoria López-Alonso et al. · 2025 · Neural Regeneration Research
  42. Loss of REST associated with Alzheimer's disease pathology is ameliorated by NAD+
    Mariá José Lagartos-Donate, Beatriz Escobar-Doncel, Shi-qi Zhang, Jun‐Ping Pan, N. González, Alexander S. Anisimov, Nicola Pietro Montaldo, Vidar Jensen, Lipeng Mao, Bailei Li et al. · 2025 · Brain
  43. Cell Adhesion Molecule Protocadherin-γC5 Ameliorates Aβ Plaque Pathogenesis by Modulating Astrocyte Function in Alzheimer's Disease
    Sun, Xiangyi, Pan, Sili, Li, Dandan, Su, Min, Zheng, Honghua, Zhang, Yun-wu, Li, Yanfang · 2025 · The Journal of Neuroscience
  44. Human induced pluripotent stem cell models for Alzheimer’s disease research: a bibliometric analysis
    Yuning Sun, Zhilong Liu, Zongbo Zhang, Yufeng Kang, Xinjiang Wang, Yiping Zhang, Yanru Liu, Pei Zhao · 2025 · Frontiers in Human Neuroscience
  45. The Impact of Apolipoprotein E Allelic Variants on Alzheimer’s Disease
    Ezequiel Serrano, Pablo G. Sanz, Francisco José Barrantes · 2021 · Springer eBooks
  46. Accelerated neuronal aging in vitro ∼melting watch ∼
    Emi Inagaki, Sho Yoshimatsu, Hideyuki Okano · 2022 · Frontiers in Aging Neuroscience
  47. Elevated p16Ink4a Expression Enhances Tau Phosphorylation in Neurons Differentiated From Human‐Induced Pluripotent Stem Cells
    Kristopher Holloway, Kashfia Neherin, Yingduo Song, Kazuhito Sato, Andrew Houston, Feng Chen, Ding Li, Hong Zhang · 2025 · Aging Cell
  48. Proinflammatory transcriptomic and kinomic alterations in astrocytes derived from patients with familial Alzheimer's disease
    Benjamin Siciliano, Nicholas D. Henkel, William G. Ryan V, A. Imami, John M. Vergis, Chong-Chong Xu, Taylen O. Arvay, Smita Sahay, Priyanka Pulvender, A. Hamoud et al. · 2025 · Brain, Behavior, & Immunity - Health
  49. Treating hippocampal neural stem cells with nano-pulsed laser therapy generates neurons resilient against amyloid-β oligomer toxicity
    Johnson Kl, Auston C. Grant, Shrinath Kadamangudi, Armando Arizpe, Johnson Kl, Rinat O. Esenaliev, Giulio Taglialatela, Maria‐Adelaide Micci · 2026 · Journal of Alzheimer s Disease
  50. A systems biology-based identification and in vivo functional screening of Alzheimer’s disease risk genes reveal modulators of memory function
    Adam D. Hudgins, Shiyi Zhou, Rachel N. Arey, Michael G. Rosenfeld, Coleen T. Murphy, Yousin Suh · 2024 · Neuron
  51. Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases
    Zi-Xiong Qiu, Xu Deng, Yuan Fu, Mei Jiang, Xiao-Jun Cui · 2024 · Journal of Neurochemistry
  52. Lithium restores nuclear REST and Mitigates oxidative stress in down syndrome iPSC-Derived neurons
    Xin-Jieh Lam, Sandra Maniam, King‐Hwa Ling, Pike-See Cheah · 2025 · Neuroscience
  53. Induced pluripotent stem cell technology: venturing into the second decade
    Yanhong Shi, Haruhisa Inoue, Jun B. Takahashi, Shinya Yamanaka · 2020 · Elsevier eBooks
  54. A Synergistic Engineering Approach to Build Human Brain Spheroids
    Djuna Katrina von Maydell, Mehdi Jorfi · 2020 · Methods in molecular biology
  55. The Molecular and Functional Changes of Neural Stem Cells in Alzheimer’s Disease: Can They be Reinvigorated to Conduct Neurogenesis
    Ejlal Abu‐El‐Rub, Ramada R. Khasawneh, Fatimah A. Almahasneh, Basma Milad Aloud, Hana M. Zegallai · 2022 · Current Stem Cell Research & Therapy
  56. Deciphering the molecular mechanism of REST regulation through DEGs and TFs in Alzheimer's disease
    Ajmal Nassar, Madhavan Nampoothiri, Prasada Chowdari Gurram, Sairaj Satarker, Dinesh Upadhya, Gayathri Shamabhat, Fayaz Shaik Mahammad · 2023 · Journal of Applied Pharmaceutical Science
  57. SIRT6-dependent functional switch via K494 modifications of RE-1 silencing transcription factor
    Adam Zaretsky, Alfredo García-Venzor, Ekaterina Eremenko, Daniel Stein, Dmitrii Smirnov, Yuval Rabuah, Rebecca A. Dryer, Dmitrii V. Kriukov, Shai Kaluski-Kopatch, Monica Einav et al. · 2024 · Cell Death and Disease
  58. ApoE4-carrying Human Astrocytes Oversupply Cholesterol into Neurons and Promote Aβ Generation
    Se-In Lee, Woojin Jeong, Sukhee Cho, Hyein G. Lee, Yonghee Jang, Yuan-Ta Lin, Li‐Huei Tsai, Jinsoo Seo · 2020 · Research Square
  59. Experimental Models of Alzheimer’s Disease
    Meltem Ercan · 2024
  60. Start the engine of neuroregeneration: A mechanistic and strategic overview of direct astrocyte-to-neuron reprogramming
    Hangyuan Jiang, Hengxing Qi, Anying Tang, Shaohua Hu, Jianbo Lai · 2025 · Ageing Research Reviews
  61. Translating Alzheimer’s disease proteomics into drug discovery opportunities
    Eleanor Drummond, Eryn L. Werry, Tomas Kavanagh, Sian Genoud, A Cho, Shihui Chen, Jonathan Du, David E. Hibbs, Michael Kassiou · 2026 · Molecular Neurodegeneration Advances
  62. Alzheimer Hastalığı’nda In Vivo ve In Vitro Modeller
    Başak Aru, Ahmet DEVELİOĞLU, Gizem Gürel, Gülderen Yanıkkaya Demirel · 2023 · Türkiye Sağlık Enstitüleri Başkanlığı Dergisi
  63. Promising Prospects for Human Cerebral Organoids to Advance Alzheimer's Disease Research
    Victoria López, Andreea Rosca, Isabel Liste, Patricia Mateos-Martínez, Raquel Coronel, Rosa González-Sastre, Sabela Martín-Benito, Victoria López · 2023 · Progress in Neurobiology
  64. A Toxicogenic Interaction between Intracellular Amyloid-β and Apolipoprotein-E
    Arpan Dey, Aditi Verma, Uchit Bhaskar, Bidyut Sarkar, Mamata Kallianpur, Vicky Vishvakarma, Anand Kant Das, Kanchan Garai, Odity Mukherjee, Kunihiko Ishii et al. · 2024 · ACS Chemical Neuroscience
  65. 3D Alzheimer's disease in a dish: Implications for drug discovery
    Luisa Quinti, Joseph Park, Emma Brand, Rudolph E. Tanzi, Doo Yeon Kim · 2020 · Elsevier eBooks
  66. Brain and Neuronal Aging: Aged Brain Controls via Gene Expression Fidelity and Master Regulatory Factors
    Nozomu Mori · 2020 · YAKUGAKU ZASSHI
  67. Secondary single-cell transcriptomic analysis reveals common molecular signatures of cerebrovascular injury between traumatic brain injury and aging
    Xinying Guo, Bangyan Zhang, Fernando Gómez‐Pinilla, Fan Gao, Zhen Zhao · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  68. Integration of genomic and transcriptomic layers in RNA‐Seq data leads to protein interaction modules with improved Alzheimer's disease associations
    Elif Düz, Atılay İlgün, Fatma Betül Bozkurt, Tunahan Çakır · 2024 · European Journal of Neuroscience
  69. LPS-induced neuroinflammation induces changes in the transcriptional profile of members of the CoRest repressive complex in the hippocampus
    Liebert Bernardes Carvalho, Kusai Baroudi, Cleiton França, Arila Adorno Scorzafava Gonçalves, Maria Martha Bernardi, Rodrigo A. da Silva · 2024 · Molecular Biology Reports
  70. Enhanced differentiation of neural progenitor cells in Alzheimer’s disease into vulnerable immature neurons
    Joonho Cho, Simsung Bae, Juyeong Jeon, Janis Lisa Transfeld, Changyeob Lee, Alexi Nott, Fan Gao, Jinsoo Seo · 2025 · iScience
  71. Intervention Role of APOE in CNS Diseases: APOE Actions and APOE Neurogenesis Capability
    Wenhua Li, Suya Ma, Min Li · 2025 · Molecular Neurobiology
  72. Obstructive sleep apnea severity related hippocampal subregional volume changes and the association with hypoxia
    Shuang Hu, Bingfang Duan, Yuanhao Li, Wenzhen Zhu · 2026 · SLEEP
  73. An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience
    Cinzia Vicidomini, Travis D. Goode, R. Yu, I. K. Mehta, Kathleen M. McAvoy, Connor H. Beveridge, Caitlin E. Randolph, Sanjay N. Iyer, Matheus B. Victor, Noelle Leary et al. · 2026 · Nature Neuroscience
  74. Expression of Repressor Element 1 Silencing Transcription Factor (REST) in Serotonin Neurons in the Adult Male Nile Tilapia (Oreochromis niloticus)
    Tomoko Soga, Shingo Nakajima, Ishwar S. Parhar · 2021 · Frontiers in Neuroanatomy
  75. Nucleoporin 153 deficiency in adult neural stem cells defines a pathological protein-network signature and defective neurogenesis in a mouse model of AD
    Claudia Colussi, Alessia Bertozzi, Lucia Leone, Marco Rinaudo, Raimondo Sollazzo, Federica Conte, Elena Paccosi, Luca Nardella, Giuseppe Aceto, Domenica Donatella Li Puma et al. · 2024 · Stem Cell Research & Therapy
  76. The search for novel targets in Alzheimer's disease—The 90s redux
    Christian Behl · 2020 · Progress in molecular biology and translational science
  77. Preservation Analysis on Spatiotemporal Specific Co-expression Networks Suggests the Immunopathogenesis of Alzheimer’s Disease
    Liyuan Guo, Yushan Liu, Jing Wang · 2021 · Frontiers in Aging Neuroscience
  78. Differentiation of Stem Cells into Neuronal Lineage: In Vitro Cell Culture and In Vivo Transplantation in Animal Models
    Shahid S. Siddiqui, Khaled Aboshamat, Sivakumar Loganathan, Zeba Kidwai Siddiqui · 2021 · Stem cell biology and regenerative medicine
  79. Identification of Molecular Signatures and Pathways to Identify Novel Therapeutic Targets in Mild Cognitive Impairment
    Vineeta Singh, Vijaya Nath Mishra · 2021 · Biomedical and Biotechnology Research Journal (BBRJ)
  80. ApoE4-carrying Human Astrocytes Oversupply Cholesterol into Neurons and Promote Aβ Generation
    Se-In Lee, Woojin Jeong, Sukhee Cho, Hyein G. Lee, Yonghee Jang, Yuan-Ta Lin, Li‐Huei Tsai, Jinsoo Seo · 2020 · Research Square
  81. Reframing Alzheimer's Disease: Guided by a New Research Framework, the Field is Poised For Greater Precision and Promising Horizons.
    Susan L. Worley · 2019 · PubMed Central
  82. Investigating the role of APOE: limitations of human pluripotent stem cell-derived cerebral organoids
    Damián G. Hernández, Louise A. Rooney, Maciej Daniszewski, Lerna M. Gulluyan, Helena Hai Liang, Anthony L. Cook, Alex William Hewitt, Alice Pébay · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  83. Mechanism, Diagnosis, Medication, Care Guidance, and Health Promotion in Alzheimer’s Disease
    Yue Dong · 2020 · E3S Web of Conferences
  84. Dysregulation of NRSF/REST via EHMT1 is associated with psychiatric disorders
    Mouhamed Alsaqati, Brittany A. Davis, Jamie Wood, Megan Jones, Lora Jones, Aishah Westwood, Olena Petter, Anthony R Isles, David E.J. Linden, Marianne B. M. van den Bree et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Caracterização de um novo RNA longo não codificador e seu provável papel no desenvolvimento neuronal
    Isabela Ichihara de Barros · 2021 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  86. Targeting Alzheimer’s disease and related dementias with CRISPR and human pluripotent stem cell technologies
    Andrew A. Sproul · 2021 · Elsevier eBooks
  87. Exploring the Serum Level of RE1 Silencing Transcription Factor in Alzheimer's Disease
    Shashank Shekhar, Manjari Tripathi, A.B. Dey, Sharmistha Dey · 2021 · Annals of the National Academy of Medical Sciences (India)
  88. Using human induced pluripotent stem cells to advance personalized/precision medicine
    Sandra Lawrynowicz Leibel, Rachael N. McVicar, Anne Bush, Evan Y. Snyder · 2022 · Elsevier eBooks
  89. Genome Editing with CRISPR‐Cas Systems
    Peter Lotfy, Patrick D. Hsu · 2022 · Wiley eBooks
  90. Advantages and limitations of hiPSC-derived neurons for the study of neurodegeneration
    Swati Mishra, Coen Van Deursen, Aiko Robert, Rik van der Kant, Jessica E. Young · 2022 · Elsevier eBooks
  91. Predictive Network Analysis Identifies JMJD6 and Other Novel Key Drivers in Alzheimer’s Disease
    Julie P. Merchant, Kuixi Zhu, Marc Henrion, Syed Shujaat Ali Zaidi, Branden Lau, Sara Moein, Melissa L. Alamprese, Richard V. Pearse, David Alan Bennett, Nilüfer Ertekin‐Taner et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  92. JUN upregulation drives aberrant transposable element mobilization, associated innate immune response, and impaired neurogenesis in Alzheimer’s disease
    Chiara Scopa, Samantha M. Barnada, M.E. Cicardi, Mo Singer, Davide Trotti, Marco Trizzino · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Alzheimer’s Research Gains Momentum and Spreads Out
    Christian Behl · 2023 · Springer eBooks
  94. Glial Cells in Alzheimer’s Disease
    Marie Louise Verkerke · 2023
  95. Apolipoprotein-E transforms intracellular Amyloid-β oligomers to a more toxic state
    Arpan Dey, Aditi Verma, Uchit Bhaskar, Bidyut Sarkar, Mamata Kallianpur, Vicky Vishvakarma, Anand Kant Das, Kanchan Garai, Odity Mukherjee, Kunihiko Ishii et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  96. Fatores genéticos e imunológicos relacionados a Síndrome Congênita do Zika em humanos
    Lucila Akune Barreiros · 2023
  97. Additional file 1 of Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease
    Pieter Jelle Visser, Lianne Maria Reus, Johan Gobom, Iris E. Jansen, Ellen Dicks, Sven J. van der Lee, Magda Tsolaki, Frans R.J. Verhey, Julius Popp, Pablo Martínez‐Lage et al. · 2022 · Figshare
  98. Analysis of transporter activity in an Alzheimer’s disease blood-brain barrier cell model
    J. Chaves · 2024 · Queensland University of Technology
  99. A human neuronal model of sporadic Alzheimer’s disease induced by FBXO2 downregulation shows Aβ aggregation, tau hyperphosphorylation and functional network impairment
    Alicia González Díaz, Andrea Possenti, Gustavo Antonio Urrutia, Yuqi Bian, Shekhar Kedia, Dorothea Böken, Christine Maria Lim, Danilo Licastro, Benedetta Mannini, David Klenerman et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Unraveling Alzheimer's disease heterogeneity:
    Eleonora M. Vromen · 2024